FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
Table of Contents UNITED STATES SECURITIES AND...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
- LOXO-292 Phase 1 Oral Presentation Upcoming at 2018 ASCO Annual Meeting - - LOXO-292 Preclinical and...
STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
STAMFORD, Conn., May 01, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Expands Illumina’s oncology offerings for NextSeq™ 550Dx with a companion diagnostic version of TruSight™ Tumor 170 for solid tumors Loxo...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.